Pregabalin is classified as a Schedule V controlled substance in the United States. The U.S. Drug Enforcement Administration (DEA) assigns controlled substance schedules based on the potential for abuse and dependence. Schedule V is the least restrictive schedule, indicating a lower potential for abuse compared to substances in higher schedules.
While pregabalin is classified as a controlled substance, it's important to note that it is not an opioid. It belongs to a class of medications known as gabapentinoids, and its mechanism of action involves binding to certain calcium channels in the central nervous system. Pregabalin is primarily used to treat neuropathic pain, fibromyalgia, and as an adjunctive therapy for certain types of seizures.
Even though it is a Schedule V substance, pregabalin can still have side effects and should be used under the supervision of a healthcare professional. It is essential for individuals to take the medication as prescribed and to report any unusual or severe side effects to their healthcare provider.
